Forum Session

Designing a Medicare Prescription Drug Benefit: Safety and Structure Considerations
March 31, 2000


Robin J. Strongin


This was the second of two Forum seminars related to the March/April 2000 thematic issue of Health Affairs which dealt with prescription drugs. This session featured the lead Health Affairs article, The Medicare Prescription Drug Benefit: How Will the Game Be Played? which was presented by authors Haiden A. Huskamp, PhD, and Richard G. Frank, PhD. They were followed by Patricia M. Danzon, PhD, who responded to the Huskamp article with her Perspective piece, Pharmaceutical Benefit Management: An Alternative Approach. Lee N. Newcomer, MD, explained why he believes Congress should consider ensuring patient safety and reducing medication errors before expanding coverage of outpatient drugs for Medicare beneficiaries.


Haiden A. Huskamp, PhD, assistant professor of health economics, Department of Health Care Policy, Harvard Medical School; Richard G. Frank, PhD, Margaret T. Morris Professor, Department of Health Care Policy, Harvard Medical School; Patricia M. Danzon, PhD, Celia Moh Professor, Health Care Department, Wharton School, University of Pennsylvania; Lee N. Newcomer, MD, Senior Vice President of Health Policy and Strategy, UnitedHealth Group

↑ back to top

Browse Topics Side ArrowDown Arrow